ZA973114B - Substituted tetracyclic tetrahydrofuran derivatives - Google Patents

Substituted tetracyclic tetrahydrofuran derivatives

Info

Publication number
ZA973114B
ZA973114B ZA973114A ZA973114A ZA973114B ZA 973114 B ZA973114 B ZA 973114B ZA 973114 A ZA973114 A ZA 973114A ZA 973114 A ZA973114 A ZA 973114A ZA 973114 B ZA973114 B ZA 973114B
Authority
ZA
South Africa
Prior art keywords
6alkyl
pct
zero
independently
optionally substituted
Prior art date
Application number
ZA973114A
Other languages
English (en)
Inventor
Pilar Gil-Lopetegui
Theo Frans Meert
Francisco Javi Fernandez-Gadea
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223868&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA973114(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA973114B publication Critical patent/ZA973114B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA973114A 1996-04-12 1997-04-11 Substituted tetracyclic tetrahydrofuran derivatives ZA973114B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96200990 1996-04-12

Publications (1)

Publication Number Publication Date
ZA973114B true ZA973114B (en) 1998-10-12

Family

ID=8223868

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA973114A ZA973114B (en) 1996-04-12 1997-04-11 Substituted tetracyclic tetrahydrofuran derivatives

Country Status (29)

Country Link
US (3) US6057441A (cs)
EP (1) EP0892793B1 (cs)
JP (1) JP3199751B2 (cs)
KR (1) KR100389298B1 (cs)
CN (1) CN1116291C (cs)
AT (1) ATE236893T1 (cs)
BG (1) BG63083B1 (cs)
BR (1) BR9706639A (cs)
CA (1) CA2232141C (cs)
CY (1) CY2382B1 (cs)
CZ (1) CZ288865B6 (cs)
DE (1) DE69720709T2 (cs)
DK (1) DK0892793T3 (cs)
EA (1) EA001002B1 (cs)
EE (1) EE03612B1 (cs)
ES (1) ES2196328T3 (cs)
HU (1) HUP9901613A3 (cs)
IL (1) IL123655A (cs)
MY (1) MY119321A (cs)
NO (1) NO317156B1 (cs)
NZ (1) NZ329953A (cs)
PL (1) PL190960B1 (cs)
PT (1) PT892793E (cs)
SI (1) SI0892793T1 (cs)
SK (1) SK283400B6 (cs)
TR (1) TR199801164T2 (cs)
TW (1) TW504506B (cs)
WO (1) WO1997038991A1 (cs)
ZA (1) ZA973114B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1116291C (zh) * 1996-04-12 2003-07-30 詹森药业有限公司 取代的四环四氢呋喃衍生物
UA52778C2 (uk) 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
US20050148018A1 (en) 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor
HRP20000310A2 (en) * 2000-05-17 2002-02-28 Pliva Farmaceutska Ind Dioniko New dibenzoazulene compounds as tumor necrosis factor inhibitors
WO2002056873A2 (en) * 2000-12-22 2002-07-25 Bayer Pharmaceuticals Corporation 2-substituted dibenzo[a,e]1,2,3-triazolo[4,5-c][7]annulen-8-ones as growth hormone secretagogues
UA79248C2 (en) 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
HUP0402325A2 (hu) 2001-12-07 2005-02-28 Janssen Pharmaceutica N.V. Eljárás cisz-fuzionált 3,3a,8,12b-tetrahidro-2H-dibenzo [3,4:6,7] ciklohepta [1,2-b]furán-származékok előállítására
EP1456193B1 (en) 2001-12-07 2005-04-27 Janssen Pharmaceutica N.V. PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2 i H /i -DIBENZO 3,4:6,7]CYCLOHEPTA 1,2-b]FURAN DERIVATIVES
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030885A2 (en) * 2003-11-03 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030956A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030957A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030953A2 (en) * 2003-11-21 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030958A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
AU2005251948A1 (en) * 2004-06-14 2005-12-22 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives
EP1761545A2 (en) 2004-06-23 2007-03-14 Janssen Pharmaceutica N.V. Novel unsaturated tetracyclic tetrahydrofuran derivatives
AU2011202995B2 (en) * 2004-12-07 2012-02-02 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
JP4912320B2 (ja) * 2004-12-07 2012-04-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換された四環式テトラヒドロピラン、ピロリジンおよびテトラヒドロチオフェン誘導体
AU2006209397B2 (en) * 2005-01-27 2011-04-07 Janssen Pharmaceutica N.V. Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disorders
MX2007014431A (es) * 2005-05-19 2008-02-11 Janssen Pharmaceutica Nv Derivados tetraciclicos de tetrahidrofurano seleccionados que contiene una cadena lateral de amina ciclica.
KR20080022084A (ko) * 2005-05-26 2008-03-10 얀센 파마슈티카 엔.브이. 신규한 치환된 테트라사이클릭 테트라하이드로푸란,피롤리딘 및 테트라하이드로티오펜 유도체 및 약제로서의이들의 용도
US8569267B2 (en) 2005-06-17 2013-10-29 Janssen Pharmaceutica, Nv Tetracyclic tetrahydrofuran derivatives containing cyclic amine side chain

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
DE2742794A1 (de) * 1976-11-15 1978-05-18 Dec Int Vorrichtung zur befoerderung von gemahlenem kaese
EP0361791B1 (en) * 1988-09-26 1995-11-08 Smithkline Beecham Farmaceutici S.p.A. Azacyclic derivatives useful as medicaments
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
FR2681320B1 (fr) * 1991-09-12 1994-01-14 Synthelabo Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique.
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
DE69631058T2 (de) * 1995-09-15 2004-06-03 Neurosearch A/S Piperindinverbindungen als calcium-kanal-blocker
CN1116291C (zh) * 1996-04-12 2003-07-30 詹森药业有限公司 取代的四环四氢呋喃衍生物

Also Published As

Publication number Publication date
EP0892793B1 (en) 2003-04-09
NO317156B1 (no) 2004-08-30
KR19990067514A (ko) 1999-08-25
JP3199751B2 (ja) 2001-08-20
EP0892793A1 (en) 1999-01-27
HUP9901613A2 (hu) 1999-09-28
EE9800326A (et) 1999-04-15
MY119321A (en) 2005-05-31
WO1997038991A1 (en) 1997-10-23
CZ288865B6 (cs) 2001-09-12
US6057441A (en) 2000-05-02
AU712154B2 (en) 1999-10-28
TR199801164T2 (xx) 1998-10-21
NO981076L (no) 1998-10-09
DE69720709T2 (de) 2004-03-11
CA2232141C (en) 2006-05-23
CN1116291C (zh) 2003-07-30
BR9706639A (pt) 1999-01-12
US6194405B1 (en) 2001-02-27
HUP9901613A3 (en) 2001-08-28
BG102820A (en) 1999-08-31
NO981076D0 (no) 1998-03-11
PL328575A1 (en) 1999-02-01
PT892793E (pt) 2003-08-29
CZ324398A3 (cs) 1999-01-13
IL123655A0 (en) 1998-10-30
SK141898A3 (en) 1999-03-12
BG63083B1 (bg) 2001-03-30
SK283400B6 (sk) 2003-07-01
KR100389298B1 (ko) 2003-10-30
DE69720709D1 (de) 2003-05-15
US6288058B1 (en) 2001-09-11
SI0892793T1 (en) 2003-10-31
TW504506B (en) 2002-10-01
CY2382B1 (en) 2004-06-04
DK0892793T3 (da) 2003-07-21
CN1205006A (zh) 1999-01-13
EE03612B1 (et) 2002-02-15
EA199800348A1 (ru) 1998-10-29
ES2196328T3 (es) 2003-12-16
IL123655A (en) 2001-03-19
PL190960B1 (pl) 2006-02-28
HK1015771A1 (en) 1999-10-22
NZ329953A (en) 1999-06-29
JP2000508327A (ja) 2000-07-04
AU2695997A (en) 1997-11-07
CA2232141A1 (en) 1997-10-23
ATE236893T1 (de) 2003-04-15
EA001002B1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
CY2382B1 (en) Substituted tetracyclic tetrahydrofuran derivatives.
CA2305612A1 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
TW333532B (en) Benzopyrans
NZ329954A (en) Isoxazolidine tetracyclic and tricyclic ring system derivatives and medicaments
ATE159255T1 (de) Chinuclidine derivate als squalen synthase inhibitoren
MY113325A (en) Substituted tetracyclic azepine derivatives
PL319870A1 (en) Derivatives of tetracyclic substituted oxazepin and thiazepin exhibiting affinity in respect to 5-ht2 receptors
SE9701396D0 (sv) Compounds
CA2232195A1 (en) Isoxazolidine derivatives
MX9703250A (es) Derivados tetraciclicos de oxazepina y tiazepina sustituidos con afinidad al receptor de 5-ht2.